Cargando…

Phage display for targeting PCSK9

Detalles Bibliográficos
Autor principal:	Ferri, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941146/ https://www.ncbi.nlm.nih.gov/pubmed/33690097 http://dx.doi.org/10.1016/j.ebiom.2021.103267

Ejemplares similares

Tumor-associated oncogenes go on (phage) display
por: Kandel, Eugene
Publicado: (2010)

The predictive utility of circulating PCSK9 levels on diabetes mellitus
por: Peng, Jia, et al.
Publicado: (2021)

Naturally Occurring PCSK9 Inhibitors
por: Adorni, Maria Pia, et al.
Publicado: (2020)

Therapeutic Phage Display-Derived Single-Domain Antibodies for Pandemic Preparedness
por: Daly, Janet M., et al.
Publicado: (2023)

Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy
por: Xu, Menglong, et al.
Publicado: (2021)

Lipoprotein(a) and PCSK9 inhibition: clinical evidence
por: Ruscica, Massimiliano, et al.
Publicado: (2020)

Construction and application of a human scFv phage display library based on Cre-LoxP recombination for anti-PCSK9 antibody selection
por: Dong, Yuan, et al.
Publicado: (2021)

Gene Therapy Targeting PCSK9
por: Katzmann, Julius L., et al.
Publicado: (2022)

Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
por: Reda, Ashraf, et al.
Publicado: (2020)

PCSK9 targets important for lipid metabolism
por: Schulz, Rainer, et al.
Publicado: (2017)

Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
por: Ferri, Nicola, et al.
Publicado: (2023)

PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma
por: Fasolato, Silvano, et al.
Publicado: (2020)

PCSK9 induces a pro-inflammatory response in macrophages
por: Ricci, Chiara, et al.
Publicado: (2018)

Envisaging bacteria as phage targets
por: Abedon, Stephen T.
Publicado: (2011)

PCSK9 as a therapeutic target for cardiovascular disease
por: Zhang, Pei-Ying
Publicado: (2017)

PCSK9: A Potential Therapeutic Target for Sepsis
por: Yuan, Yuan, et al.
Publicado: (2020)

Phage Display Informatics
por: Huang, Jian, et al.
Publicado: (2013)

Antibody Phage Display
por: Aitken, Rob
Publicado: (2008)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

Expression of a PCSK9 Gain-of-Function Mutation in C57BL/6J Mice to Facilitate Angiotensin II-Induced AAAs
por: Sawada, Hisashi, et al.
Publicado: (2022)

Eliminating helper phage from phage display
por: Chasteen, L., et al.
Publicado: (2006)

Targeting osteosarcoma vasculature with peptide obtained by phage display
por: Guan, Mingqiang, et al.
Publicado: (2014)

The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)

A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines
por: Goksøyr, Louise, et al.
Publicado: (2022)

Thinking about microcolonies as phage targets
por: Abedon, Stephen T.
Publicado: (2012)

Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
por: Punch, Emily, et al.
Publicado: (2022)

Landscape Phage: Evolution from Phage Display to Nanobiotechnology
por: Petrenko, Valery A.
Publicado: (2018)

Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9
por: Adorni, Maria Pia, et al.
Publicado: (2017)

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
por: Ko, Dennis T., et al.
Publicado: (2018)

The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway
por: Ataei, Sarina, et al.
Publicado: (2023)

PCSK9 Induces Rat Smooth Muscle Cell Proliferation and Counteracts the Pleiotropic Effects of Simvastatin
por: Lupo, Maria Giovanna, et al.
Publicado: (2021)

Generation of a helper phage for the fluorescent detection of peptide-target interactions by dual-display phages
por: De Plano, Laura Maria, et al.
Publicado: (2023)

Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015)

Targeting membrane proteins for antibody discovery using phage display
por: Jones, Martina L., et al.
Publicado: (2016)

Phage display screening of therapeutic peptide for cancer targeting and therapy
por: Saw, Phei Er, et al.
Publicado: (2019)

Pleiotropic Effects of PCSK-9 Inhibitors
por: Basiak, Marcin, et al.
Publicado: (2021)

PCSK9 Antibodies for the Treatment of Hypercholesterolemia
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2014)

PCSK9 and Atherosclerosis - Lipids and Beyond
por: Shapiro, Michael D., et al.
Publicado: (2017)

An Update on the Role of PCSK9 in Atherosclerosis
por: Yurtseven, Ece, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uct66nv2m1tbseg5aicg9ouehq